Bredt David sold RAPP
December 31, 2025 · Form 4 insider transaction
Bredt David sold 6,567 shares of Rapport Therapeutics, Inc. at $30.05 per share, a transaction worth $197.3K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 5 days after the transaction.
Footnotes
Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units, and does not represent a discretionary trade by the reporting person.; The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.04 to $30.05. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.